BETSY CORDELL: Open Payments
NPI 1841526001 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,776 in 78 payments from 19 companies in 2025. Trend: 2023 $1,782 · 2024 $2,274 · 2025 $1,776
Food & beverage: $1,776
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $711 |
| Novo Nordisk Inc | 8 | $183 |
| Lilly USA, LLC | 10 | $145 |
| PFIZER INC. | 7 | $118 |
| Abbott Laboratories | 5 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $107 |
| ABBVIE INC. | 6 | $93 |
| Phathom Pharmaceuticals, Inc. | 5 | $54 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, MOUNJARO, Kerendia, Ozempic, PREVNAR 20, QULIPTA.
Industry payments across TN — which companies pay providers there.
